babble home - news for the rest of us
today's active topics

Post New Topic  Post A Reply
FAQ | Forum Home
  next oldest topic   next newest topic
» babble   » right brain babble   » humanities & science   » Important Advance In Study of Leukemia

Email this thread to someone!    
Author Topic: Important Advance In Study of Leukemia
Babbler # 490

posted 21 September 2004 07:14 PM      Profile for DrConway     Send New Private Message      Edit/Delete Post  Reply With Quote 
Researchers Eliminate Leukemia In Mice, Demonstrating Potential New Approach To Cancer Drug Therapy

Letai is the lead author and Korsmeyer, a Howard Hughes Medical Institute investigator, is the senior author of a report published in the Sept. 21 issue of Cancer Cell. The other authors are Mia D. Sorcinelli and Caroline Beard. The report describes an experiment with laboratory mice genetically modified to be highly prone to developing leukemia. The mice were also modified so that the BCL-2 protein could be turned off by adding an antibiotic to the animals' water.

The scientists observed 28 mice, which, at 5 to 7 weeks of age, had developed leukemia. Fourteen were given the antibiotic in their water to turn off the BCL-2 genes. Within three days, the treated animals had a decline in leukemia cells and their white blood cell counts became normal within 10 days.

There was no such improvement in the untreated mice, whose cancers resisted death because of their active BCL-2 genes: they all died by just over 100 days of age. By contrast, five of the mice with silenced BCL-2 genes survived for over 200 days, and one of them lived more than a year.

Mice, being mammals, do share substantial genetic and physiological similarities to humans, and so this research is quite germane to determining how to combat leukemia in humans.

Quite exciting.

From: You shall not side with the great against the powerless. | Registered: May 2001  |  IP: Logged

All times are Pacific Time  

Post New Topic  Post A Reply Close Topic    Move Topic    Delete Topic next oldest topic   next newest topic
Hop To:

Contact Us | | Policy Statement

Copyright 2001-2008